APA (7th ed.) Citation

CR, G., LM, W., KN, H., JO, E., NY, S., AM, F., . . . SQ, H. (2018). AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD. JCI insight, 3(22), . https://doi.org/10.1172/jci.insight.123538

Chicago Style (17th ed.) Citation

CR, Giesige, et al. "AAV-mediated Follistatin Gene Therapy Improves Functional Outcomes in the TIC-DUX4 Mouse Model of FSHD." JCI Insight 3, no. 22 (2018). https://doi.org/10.1172/jci.insight.123538.

MLA (9th ed.) Citation

CR, Giesige, et al. "AAV-mediated Follistatin Gene Therapy Improves Functional Outcomes in the TIC-DUX4 Mouse Model of FSHD." JCI Insight, vol. 3, no. 22, 2018, https://doi.org/10.1172/jci.insight.123538.